BE601394A - - Google Patents
Info
- Publication number
- BE601394A BE601394A BE601394DA BE601394A BE 601394 A BE601394 A BE 601394A BE 601394D A BE601394D A BE 601394DA BE 601394 A BE601394 A BE 601394A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- piperazine derivatives
- preparation
- chlorophenyl
- cough
- Prior art date
Links
- 150000004885 piperazines Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- 229940066771 systemic antihistamines Piperazine derivatives Drugs 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 20
- 239000000047 product Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 2
- 229960004415 Codeine Phosphate Drugs 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- -1 2,3-dihydroxypropyl Chemical group 0.000 description 1
- 241001633942 Dais Species 0.000 description 1
- 206010013663 Drug dependence Diseases 0.000 description 1
- 210000003801 Laryngeal Nerves Anatomy 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001181114 Neta Species 0.000 description 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N Phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE601394A true BE601394A (de) |
Family
ID=192580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE601394D BE601394A (de) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE601394A (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699911A (en) * | 1983-12-29 | 1987-10-13 | Dompe' Farmaceutici S.P.A. | Levo and dextro dropropizine having antitussive activity |
EP0349066A1 (de) * | 1988-06-25 | 1990-01-03 | Dsm N.V. | Herstellung von Enantiomeren des Dropropizins |
EP0409044A2 (de) * | 1989-07-20 | 1991-01-23 | DOMPE' FARMACEUTICI S.p.A. | Verfahren zur optischen Trennung von Dropropizin |
-
0
- BE BE601394D patent/BE601394A/fr unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4699911A (en) * | 1983-12-29 | 1987-10-13 | Dompe' Farmaceutici S.P.A. | Levo and dextro dropropizine having antitussive activity |
EP0349066A1 (de) * | 1988-06-25 | 1990-01-03 | Dsm N.V. | Herstellung von Enantiomeren des Dropropizins |
EP0409044A2 (de) * | 1989-07-20 | 1991-01-23 | DOMPE' FARMACEUTICI S.p.A. | Verfahren zur optischen Trennung von Dropropizin |
EP0409044A3 (en) * | 1989-07-20 | 1991-05-29 | Dompe' Farmaceutici S.P.A. | A process for the optical resolution of dropropizine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE898570A (fr) | Nouveaux amides et imides carboxyliques, procédés pour leur préparation et composition pharmaceutique les contenant. | |
EP0073161B1 (de) | Pyridazin-Derivate mit einer Wirkung auf das Zentralnervensystem | |
EP0213984B1 (de) | Indolcarboxamidderivate, ihre Salze, Verfahren und Zwischenprodukte, Anwendung als Heilmittel und Zusammensetzungen die sie enthalten | |
BE601394A (de) | ||
CA2071983C (fr) | Derive de la beta-phenylisoserine, sa preparation et son emploi | |
FR2535721A1 (fr) | Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives | |
FR2522658A1 (fr) | Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation | |
JPS6121235B2 (de) | ||
EP0150139A2 (de) | Indol-Ethylphenyl-Derivate, ihre Salze, Vefahren zur Herstellung, Anwendung als Heilmittel und Zusammensetzungen die sie enthalten | |
EP0209435B1 (de) | Hydroxyalkoxy-4-phenylpropylindolderivate, ihre Salze, Verfahren und Zwischenprodukte zur Herstellung, Anwendung als Heilmittel und Zusammensetzungen die sie enthalten | |
CA1211105A (fr) | Procede pour la preparation de derives de p-acylaminophenol et derives obtenus par ce procede | |
FR2547822A1 (fr) | Acylpiperazinoquinazolines substituees utiles comme medicaments et procede pour leur preparation | |
EP0183577B1 (de) | Auf das Zentralnervensystem wirksame Thiadiazolderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
FR2491456A1 (de) | ||
BE669202A (de) | ||
CH397693A (fr) | Procédé de préparation de pipérazines | |
FR2765223A1 (fr) | Nouveaux derives tricycliques du benzimidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
JPH0656786A (ja) | 新規なジアシルグリセロールニコチネート類 | |
EP0275221B1 (de) | N-(1H-indol-4-yl)-Benzamidderivate, ihre Salze und deren Anwendung als Heilmittel und Zusammenstellungen, die sie enthalten | |
US3422141A (en) | 3,4-dihydroxyphenylalkanamides | |
CH407147A (fr) | Procédé de préparation de composés antitumoraux | |
FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
CA1161444A (fr) | Procede de preparation de derives du cycloheptindolol et de leurs sels avec les acides | |
FR2572730A1 (fr) | Nouveaux derives de l'arsenic, leur preparation et leur application, notamment comme medicaments antiparasitaires | |
FR2548180A1 (fr) | Amides d'acides carboxyliques et leurs derives, leur preparation et leur application en therapeutique |